𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Impaired adrenal function after glucocorticoid therapy in children with acute lymphoblastic leukemia

✍ Scribed by Petersen, Kamilla B. ;Müller, Jørn ;Rasmussen, Mette ;Schmiegelow, Kjeld


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
84 KB
Volume
41
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Background

Glucocorticoids are commonly used in the treatment of childhood acute lymphoblastic leukemia (ALL). The purpose of this study was to assess the incidence of adrenal insufficiency and the time for children with ALL to recover after treatment with the glucorticoids prednisolone or dexamethasone.

Procedure

Seventeen children, 2–15 years, with ALL were studied after receiving prednisolone (60 mg/m^2^/day, n = 10) for 5 weeks during remission induction therapy or dexamethasone (10 mg/m^2^/day, n = 7) for 3 weeks during reinduction therapy. Both drugs were tapered over 9 days. The adrenal function was assessed by an ACTH stimulation test within 2 weeks after discontinuing glucocorticoid therapy. In case of adrenal insufficiency, the ACTH test was repeated at 3–5 weeks interval, and patients were put on hydrocortisone substitution therapy.

Results

Three out of ten patients had a normal adrenal function within the first 2 weeks after prednisolone therapy. Another three patients recovered within 7 weeks, whereas the remaining four patients still showed adrenal insufficiency at the end of follow‐up after 2.5–4 months. For dexamethasone, two out of seven patients showed a normal adrenal function within the first 2 weeks. Of the remaining patients, two recovered within 7 weeks, whereas three patients still had a demonstrated adrenal insufficiency at the end of follow‐up after 4–8 months.

Conclusions

Adrenal insufficiency occurs and may persist for several months in children with ALL after treatment with high doses of prednisolone or dexamethasone. Med Pediatr Oncol 2003;41:110–114. © 2003 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Strength and functional mobility in chil
✍ Gocha Marchese, Victoria ;Chiarello, Lisa A. ;Lange, Beverly J. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

## Abstract ## Background The purposes of this pilot study were as follows: (1) to evaluate tools for measuring neuropathy in children with acute lymphoblastic leukemia (ALL), (2) to examine strength and functional mobility in children with ALL, and (3) to determine if there is a relationship betw

Liver function studies in children with
✍ Bessho, Fumio ;Kinumaki, Hiroshi ;Yokota, Shunichiro ;Hayashi, Yasuhide ;Kobayas 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 380 KB

## Abstract We investigated liver function in 27 children with acute lymphocytic leukemia (ALL) after cessation of therapy. Induction therapy consisted of prednisolone + vincristine (VP regimen) alone (16 patients) or with addition of daunorubicin (4 patients) or L‐asparaginase (7 patients). Patien

Therapy-related changes in body size in
✍ Jacques Baillargeon; Anne-Marie Langevin; Margaret Lewis; James J. Grady; Paul J 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

## Abstract ## BACKGROUND The objective of this study was to examine changes over time in body mass index (BMI) from diagnosis through chemotherapy for pediatric patients with B‐precursor acute lymphoblastic leukemia (ALL). ## METHODS The study cohort consisted of 141 white Hispanic pediatric pa

Motor nervous pathway function is impair
✍ Harila-Saari, Arja H. ;Huuskonen, Usko E.J. ;Tolonen, Uolevi ;Vainionpää, Leena 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

## Abstract ## Background The objective was to evaluate whether motor nervous pathways are affected when patients are treated for childhood acute lymphoblastic leukemia (ALL). ## Procedure Thirty‐two children with ALL were studied at the end of treatment by means of motor evoked potentials (MEPs